1 is false - this article's 91% includes data from before, during, and after the J&J trial. So it covers times when the variants were more active as well.
Further, the JNJ clinical trial data was from a population where the Brazilian variant, the most serious of the variants, was likely more widespread than this PFE data which seems to focus more on the relatively less dangerous South African variant.